M4MM

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

  • TerrAscend

TerrAscend Reduces Outstanding Debt by US$30 Million

TORONTO - TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), a North American cannabis operator, announced that its subsidiary, WDB Holding MI, Inc. (DE), and all subsidiaries of TerrAscend, refinanced the existing senior secured term loan of ...

  • Ayr Wellness

Ayr Wellness Begins Adult-Use Sales at Somerville

MIAMI - Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), begins adult-use sales alongside its established medical sales at its Somerville, MA retail location. Located at 240 Elm St, Somerville, MA 02144, Sira Naturals Somerville is ...

  • CBD market, Cannabis Extract Market, Cannabidiol

Can “CB2 Oil” Help Control Blood Sugar?

TORONTO, Nov. 23, 2022 November 2022 marked the 100 anniversary of a truly Canadian innovation: the discovery of insulin. This life-saving hormone can help control blood sugar and prevent the disastrous consequences that set in when blood sugar ...

Subscribe To Our Newsletter